Patterns of Early Rejection in Renal Retransplantation: A Single-Center Experience

Figure 2

The average blood lymphocyte counts in retransplant patients before and after Thymoglobulin induction therapy. A satisfactory decline of peripheral blood lymphocyte count in the retransplant group was achieved with a 5-day period of Thymoglobulin induction therapy (total dosage: 125–150 mg).